RESEARCH-USE BIOSIMILAR ANTIBODY

Tamgiblimab

Monoclonal antibody · IgG4

TIGITIgG4RUO

Tamgiblimab (IBI939) is a fully human monoclonal antibody targeting T-cell immunoreceptor with immunoglobulin and ITIM domains (TIGIT). Tamgiblimab has anticancer effects.

TARGETTIGIT
YMonoclonal antibody
CATALOGSC-BS-137
CATALOG NUMBERSC-BS-137
MOLECULAR WEIGHTApprox. 144.34 kDa
PRODUCT FORMATMonoclonal antibody

A research-use configuration for comparative antibody studies

Tamgiblimab (IBI939) is a fully human monoclonal antibody targeting T-cell immunoreceptor with immunoglobulin and ITIM domains (TIGIT). Tamgiblimab has anticancer effects.

Tamgiblimab is a recombinant research-use antibody directed against TIGIT.

START A CONVERSATION

Tell us about your research goals.

For quotes, sample requests or technical support, start with your target and experimental context.

Contact StellaCyte
Tamgiblimab | StellaCyte